Cargando…

Risk factors for concomitant positive midstream urine culture in patients presenting with symptomatic ureterolithiasis

In patients with symptomatic ureterolithiasis, immediate treatment of concomitant urinary tract infection (UTI) may prevent sepsis. However, urine cultures require at least 24 h to confirm or exclude UTI, and therefore, clinical variables may help to identify patients who require immediate empirical...

Descripción completa

Detalles Bibliográficos
Autores principales: Grossmann, Nico C., Schuettfort, Victor M., Betschart, Jeannine, Becker, Anton S., Hermanns, Thomas, Keller, Etienne X., Fankhauser, Christian D., Kranzbühler, Benedikt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110449/
https://www.ncbi.nlm.nih.gov/pubmed/35441879
http://dx.doi.org/10.1007/s00240-022-01323-4
_version_ 1784709106716639232
author Grossmann, Nico C.
Schuettfort, Victor M.
Betschart, Jeannine
Becker, Anton S.
Hermanns, Thomas
Keller, Etienne X.
Fankhauser, Christian D.
Kranzbühler, Benedikt
author_facet Grossmann, Nico C.
Schuettfort, Victor M.
Betschart, Jeannine
Becker, Anton S.
Hermanns, Thomas
Keller, Etienne X.
Fankhauser, Christian D.
Kranzbühler, Benedikt
author_sort Grossmann, Nico C.
collection PubMed
description In patients with symptomatic ureterolithiasis, immediate treatment of concomitant urinary tract infection (UTI) may prevent sepsis. However, urine cultures require at least 24 h to confirm or exclude UTI, and therefore, clinical variables may help to identify patients who require immediate empirical broad-spectrum antibiotics and surgical intervention. Therefore, we divided a consecutive cohort of 705 patients diagnosed with symptomatic ureterolithiasis at a single institution between 2011 and 2017 into a training (80%) and a testing cohort (20%). A machine-learning-based variable selection approach was used for the fitting of a multivariable prognostic logistic regression model. The discriminatory ability of the model was quantified by the area under the curve (AUC) of receiver-operating curves (ROC). After validation and calibration of the model, a nomogram was created, and decision curve analysis (DCA) was used to evaluate the clinical net-benefit. UTI was observed in 40 patients (6%). LASSO regression selected the variables elevated serum CRP, positive nitrite, and positive leukocyte esterase for fitting of the model with the highest discriminatory ability. In the testing cohort, model performance evaluation for prediction of UTI showed an AUC of 82 (95% CI 71.5–95.7%). Model calibration plots showed excellent calibration. DCA showed a clinically meaningful net-benefit between a threshold probability of 0 and 80% for the novel model, which was superior to the net-benefit provided by either one of its singular components. In conclusion, we developed and internally validated a logistic regression model and a corresponding highly accurate nomogram for prediction of concomitant positive midstream urine culture in patients presenting with symptomatic ureterolithiasis.
format Online
Article
Text
id pubmed-9110449
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-91104492022-05-18 Risk factors for concomitant positive midstream urine culture in patients presenting with symptomatic ureterolithiasis Grossmann, Nico C. Schuettfort, Victor M. Betschart, Jeannine Becker, Anton S. Hermanns, Thomas Keller, Etienne X. Fankhauser, Christian D. Kranzbühler, Benedikt Urolithiasis Original Article In patients with symptomatic ureterolithiasis, immediate treatment of concomitant urinary tract infection (UTI) may prevent sepsis. However, urine cultures require at least 24 h to confirm or exclude UTI, and therefore, clinical variables may help to identify patients who require immediate empirical broad-spectrum antibiotics and surgical intervention. Therefore, we divided a consecutive cohort of 705 patients diagnosed with symptomatic ureterolithiasis at a single institution between 2011 and 2017 into a training (80%) and a testing cohort (20%). A machine-learning-based variable selection approach was used for the fitting of a multivariable prognostic logistic regression model. The discriminatory ability of the model was quantified by the area under the curve (AUC) of receiver-operating curves (ROC). After validation and calibration of the model, a nomogram was created, and decision curve analysis (DCA) was used to evaluate the clinical net-benefit. UTI was observed in 40 patients (6%). LASSO regression selected the variables elevated serum CRP, positive nitrite, and positive leukocyte esterase for fitting of the model with the highest discriminatory ability. In the testing cohort, model performance evaluation for prediction of UTI showed an AUC of 82 (95% CI 71.5–95.7%). Model calibration plots showed excellent calibration. DCA showed a clinically meaningful net-benefit between a threshold probability of 0 and 80% for the novel model, which was superior to the net-benefit provided by either one of its singular components. In conclusion, we developed and internally validated a logistic regression model and a corresponding highly accurate nomogram for prediction of concomitant positive midstream urine culture in patients presenting with symptomatic ureterolithiasis. Springer Berlin Heidelberg 2022-04-20 2022 /pmc/articles/PMC9110449/ /pubmed/35441879 http://dx.doi.org/10.1007/s00240-022-01323-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Grossmann, Nico C.
Schuettfort, Victor M.
Betschart, Jeannine
Becker, Anton S.
Hermanns, Thomas
Keller, Etienne X.
Fankhauser, Christian D.
Kranzbühler, Benedikt
Risk factors for concomitant positive midstream urine culture in patients presenting with symptomatic ureterolithiasis
title Risk factors for concomitant positive midstream urine culture in patients presenting with symptomatic ureterolithiasis
title_full Risk factors for concomitant positive midstream urine culture in patients presenting with symptomatic ureterolithiasis
title_fullStr Risk factors for concomitant positive midstream urine culture in patients presenting with symptomatic ureterolithiasis
title_full_unstemmed Risk factors for concomitant positive midstream urine culture in patients presenting with symptomatic ureterolithiasis
title_short Risk factors for concomitant positive midstream urine culture in patients presenting with symptomatic ureterolithiasis
title_sort risk factors for concomitant positive midstream urine culture in patients presenting with symptomatic ureterolithiasis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110449/
https://www.ncbi.nlm.nih.gov/pubmed/35441879
http://dx.doi.org/10.1007/s00240-022-01323-4
work_keys_str_mv AT grossmannnicoc riskfactorsforconcomitantpositivemidstreamurinecultureinpatientspresentingwithsymptomaticureterolithiasis
AT schuettfortvictorm riskfactorsforconcomitantpositivemidstreamurinecultureinpatientspresentingwithsymptomaticureterolithiasis
AT betschartjeannine riskfactorsforconcomitantpositivemidstreamurinecultureinpatientspresentingwithsymptomaticureterolithiasis
AT beckerantons riskfactorsforconcomitantpositivemidstreamurinecultureinpatientspresentingwithsymptomaticureterolithiasis
AT hermannsthomas riskfactorsforconcomitantpositivemidstreamurinecultureinpatientspresentingwithsymptomaticureterolithiasis
AT kelleretiennex riskfactorsforconcomitantpositivemidstreamurinecultureinpatientspresentingwithsymptomaticureterolithiasis
AT fankhauserchristiand riskfactorsforconcomitantpositivemidstreamurinecultureinpatientspresentingwithsymptomaticureterolithiasis
AT kranzbuhlerbenedikt riskfactorsforconcomitantpositivemidstreamurinecultureinpatientspresentingwithsymptomaticureterolithiasis